SCHEDULE 13G/A: BlackRock Discloses 9.7% Passive Stake in IDEAYA BIOSCIENCES INC

BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 9.7% in IDEAYA BIOSCIENCES INC as of December 31, 2024.

Summary

• BlackRock, Inc. reported beneficial ownership of 8,376,080 shares of Common Stock in IDEAYA BIOSCIENCES INC.
• This ownership represents 9.7% of the class of securities.
• BlackRock, Inc. holds sole voting power over 8,114,235 shares and sole dispositive power over 8,376,080 shares.
• The filing is an Amendment No. 3 to Schedule 13G, indicating a change from previous filings.
• BlackRock, Inc. is classified as a parent holding company (HC) for this filing.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of passive ownership, providing no positive or negative sentiment regarding the issuer's performance or prospects. The sentiment is neutral.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing reflects a significant passive investment by a major asset manager, BlackRock, in a biotechnology company, IDEAYA BIOSCIENCES INC. Such disclosures are standard for large institutional investors reaching or crossing certain ownership thresholds and do not inherently indicate specific industry trends beyond general investment activity.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a major institutional investor like BlackRock may be viewed positively by other shareholders as a vote of confidence, potentially influencing market perception and liquidity.

Key Dates

Keywords

BlackRock, IDEAYA BIOSCIENCES INC, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Passive Investment, SEC Filing